Abstract 4371560: Obicetrapib in patients with dyslipidemia with or without atherosclerotic cardiovascular disease risk: A meta-analysis of randomized controlled trials

Authors

Ahmed Emara
Abdalhakim Shubietah, Advocate Health - MidwestFollow
Mohamed Elgendy
et al

Recommended Citation

Emara A, Shubietah A, Elgendy M, et al. Abstract 4371560: Obicetrapib in Patients with Dyslipidemia with or without Atherosclerotic Cardiovascular Disease Risk: A Meta-Analysis of Randomized Controlled Trials. Circulation. 2025;152(Suppl_3):A4371560-A4371560. doi:10.1161/circ.152.suppl_3.4371560

Affiliations

Advocate Illinois Masonic Medical Center

Type

Abstract